Modeling Alzheimer's disease in transgenic mice: effect of age and of Presenilin1 on amyloid biochemistry and pathology in APP/London mice
- 1 September 2000
- journal article
- review article
- Published by Elsevier in Experimental Gerontology
- Vol. 35 (6-7), 831-841
- https://doi.org/10.1016/s0531-5565(00)00149-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Aggressive behaviour in transgenic mice expressing APP is alleviated by serotonergic drugsNeuroReport, 1998
- Transgenic mice expressing an α-secretion mutant of the amyloid precursor protein in the brain develop a progressive CNS disorderBehavioural Brain Research, 1998
- Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenesNature Medicine, 1998
- Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor ProteinsNeuron, 1997
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997
- Amyloid precursor protein processing and Aβ 42 deposition in a transgenic mouse model of Alzheimer diseaseProceedings of the National Academy of Sciences, 1997
- Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic miceNature Medicine, 1997
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic MiceScience, 1996
- Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor proteinNature, 1995